Laboratorios Farmaceuticos Rovi, S.A.

MSE:ROVI.MC

65.75 (EUR) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

202320222021202020192018201720162015201420132012201120102009200820072006
Operating Activities:
Net Income 220.408257.967182.62872.58141.8816.6817.52227.88220.89825.63424.25120.83818.92825.92124.30728.15819.8584.744
Depreciation & Amortization 24.33122.87121.36419.59318.21612.04411.47911.0239.9758.8846.9435.324.7093.5861.3091.5010.7440.35
Deferred Income Tax 0013.716000000000000000
Stock Based Compensation 001.403000000000000000
Change In Working Capital -34.448-56.973-64.034-63.751-63.665-24.434-9.213.0772.743-7.7861.474-4.232-7.9417.266-9.682-12.968-13.3378.93
Accounts Receivables 19.471-26.82-74.1877.468-20.409-9.6053.5344.1316.508000000000
Inventory -29.294-71.591-23.427-70.398-67.227-21.348-6.454-4.945.041-11.229-2.522-14.9190.518-9.802-2.244-4.897-0.21.258
Accounts Payables -23.92341.67235.358-0.81123.9536.54-6.9113.505-9.276000000000
Other Working Capital -0.702-0.234-1.778-0.010.018-3.086-2.74618.017-2.2983.4433.99610.687-8.45917.068-7.438-8.071-13.1377.672
Other Non Cash Items -97.04413.737-5.63618.453-5.4754.241-1.762-6.456-4.224-3.73-2.852-2.312-3.012-15.583-6.312-4.03-6.114-6.305
Operating Cash Flow 113.247237.602149.44146.876-9.0448.53118.03945.52629.39223.00229.81619.61412.68421.199.62212.6611.1517.719
Investing Activities:
Investments In Property Plant And Equipment -55.187-51.388-40.94-39.692-40.525-26.459-19.944-18.076-19.901-25.054-24.683-13.72-8.353-5.576-2.986-9.737-11.733-4.043
Acquisitions Net 1.20.0780.0330.0630.0020.050.450.9970.041012.005-10.2781.519010.468000
Purchases Of Investments 1.393-5.87000008.396-0.170-0.103-31.914-12.465-25.182-2.131000
Sales Maturities Of Investments 0.0880.020000.050.451016.20111.95714.7512502.788000
Other Investing Activites 0.4780.0060.0680.0040.0510.1670.31-8.6150.8170.403-12.7081.3672.616.6340.2641.59714.066-4.73
Investing Cash Flow -52.028-57.154-40.839-39.625-40.472-26.242-19.184-16.298-19.254-8.45-13.532-39.7948.311-24.1248.403-8.142.333-8.773
Financing Activities:
Debt Repayment -13.654-6.768-6.192-13.179-21.242-16.23-13.084-10.274-5.671-18.907-9.384-8.8330000-2.265-1.732
Common Stock Issued 52.63977.76642.32837.4884.8710.9861.0110.4461.3981.3765.2611.4880.1560.6831.945000
Common Stock Repurchased -133.9-177.008-78.785-37.255-4.718-1.138-0.532-0.987-6.546-3.345-3.466-1.838-0.147-1.4020000
Dividends Paid -69.049-51.007-21.132-9.7-4.42-5.952-9.025-6.853-8.346-8.042-6.78-6.3-8.547-7.0110-3.915-9-4
Other Financing Activities 3.1222.481.0521.13146.9494.85622.0970.56711.60721.6360.9012.7573.3998.361.0241.82112.0437.736
Financing Cash Flow -160.842-154.537-62.729-21.51521.43172.5220.467-17.101-7.558-7.282-13.468-12.726-5.1390.632.969-2.0940.7782.004
Other Information:
Effect Of Forex Changes On Cash 0-0.0010000000000000000
Net Change In Cash -99.62325.9145.873-14.264-28.08554.811-0.67812.1272.587.272.816-32.90615.856-2.30420.9942.4274.2620.95
Cash At End Of Period 25.322124.94599.03553.16267.42695.51140.741.37829.25126.67119.40116.58549.49133.63531.49119.6417.21312.951